logo
Plus   Neg
Share
Email

Raytheon Technologies Guides FY21 Adj. EPS In Line With Estimates - Quick Facts

While reporting financial results for the fourth quarter and fiscal 2020 on Tuesday, aerospace and defense company Raytheon Technologies Corp. (RTX) initiated its adjusted earnings and sales outlook for the first quarter and full-year 2021.

For fiscal 2021, the company now projects adjusted earnings in a range of $3.40 to $3.70 per share on sales between $63.4 billion and $65.4 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $3.46 per share on sales of $67.3 billion for the year. Analysts' estimates typically exclude special items.

For the first quarter, the company expects adjusted earnings in a range of $0.70 to $0.75 per share on sales between $14.8 billion and $15.4 billion. The Street is looking for earnings of $0.70 per share on sales of $15.74 billion for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Performance Food Group Co. announced Tuesday its agreement to acquire Core-Mark Holding Co., Inc., a wholesale distributor to the convenience retail industry, in around $2.5 billion stock and cash transaction, including net debt. In pre-markey activity on Nasdaq, Core-Mark shares were gaining around 9 percent to trade at $45.86. Retail giant Walmart Inc. reported Tuesday a profit for the first quarter of fiscal 2022 that declined 31.6 percent from last year, hurt by net losses on equity investments, However, adjusted earnings per share and quarterly revenues topped analysts' expectations. The retailer also raised its guidance for the second quarter and for the full-year 2022. European Medicines Agency or EMA announced that Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech, can have more flexible storage conditions, including up to one month in a normal fridge. The proposed change in the approved storage conditions, recommended by EMA's human medicines committee or CHMP, will help in easy handling of the vaccine in vaccination centres across the EU.
Follow RTT